These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7962474)
41. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri. Murphy AA; Castellano PZ Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415 [TBL] [Abstract][Full Text] [Related]
42. Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment. Slayden OD; Hirst JJ; Brenner RM Endocrinology; 1993 Apr; 132(4):1845-56. PubMed ID: 8462480 [TBL] [Abstract][Full Text] [Related]
43. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys. Remohi J; Balmaceda JP; Rojas FJ; Asch RH Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390 [TBL] [Abstract][Full Text] [Related]
44. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063 [TBL] [Abstract][Full Text] [Related]
45. Endometrial effects of long-term low-dose administration of RU486. Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059 [TBL] [Abstract][Full Text] [Related]
46. Evidence that atrazine and diaminochlorotriazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action. McMullin TS; Andersen ME; Nagahara A; Lund TD; Pak T; Handa RJ; Hanneman WH Toxicol Sci; 2004 Jun; 79(2):278-86. PubMed ID: 15056801 [TBL] [Abstract][Full Text] [Related]
47. Effects of progesterone (P) and antiprogestin RU486 on LH and FSH release by incubated pituitaries from rats treated with the SERM LY11701 8-HCl and/or recombinant human FSH. Bellido C; Aguilar R; Garrido-Gracia JC; Sánchez-Criado JE J Endocrinol Invest; 2002 Sep; 25(8):702-8. PubMed ID: 12240902 [TBL] [Abstract][Full Text] [Related]
48. Estrogen-induced calbindin-D 9k gene expression in the rat uterus during the estrous cycle: late antagonistic effect of progesterone. L'Horset F; Blin C; Brehier A; Thomasset M; Perret C Endocrinology; 1993 Feb; 132(2):489-95. PubMed ID: 8425470 [TBL] [Abstract][Full Text] [Related]
49. Inappropriate ovarian feedback in basal gonadotropin secretion in 4-day cyclic rat treated with mifepristone: role of endogenous estradiol. Tébar M; Bellido C; Aguilar R; Sánchez-Criado JE J Endocrinol Invest; 1994 Jun; 17(6):425-30. PubMed ID: 7930387 [TBL] [Abstract][Full Text] [Related]
50. Effects of luteal phase administration of mifepristone (RU486) and prostaglandin analogue or inhibitor on endometrium in the rhesus monkey. Nayak NR; Ghosh D; Sengupta J Hum Reprod; 1998 Apr; 13(4):1047-56. PubMed ID: 9619569 [TBL] [Abstract][Full Text] [Related]
51. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. Mäentausta O; Svalander P; Danielsson KG; Bygdeman M; Vihko R J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors. Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199 [TBL] [Abstract][Full Text] [Related]
53. Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle. Suganuma C; Kuroiwa T; Tanaka T; Kamomae H Anim Reprod Sci; 2007 Oct; 101(3-4):285-94. PubMed ID: 17027203 [TBL] [Abstract][Full Text] [Related]
54. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells. Jeng MH; Langan-Fahey SM; Jordan VC Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763 [TBL] [Abstract][Full Text] [Related]
55. Effects of daily low dose mifepristone on endometrial maturation and proliferation. Cameron ST; Critchley HO; Thong KJ; Buckley CH; Williams AR; Baird DT Hum Reprod; 1996 Nov; 11(11):2518-26. PubMed ID: 8981147 [TBL] [Abstract][Full Text] [Related]
56. Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor. Haluska GJ; West NB; Novy MJ; Brenner RM J Clin Endocrinol Metab; 1990 Jan; 70(1):181-6. PubMed ID: 2294130 [TBL] [Abstract][Full Text] [Related]
57. Follicular and luteal progesterone play different roles synchronizing pituitary and ovarian events in the 4-day cyclic rat. Tébar M; Ruiz A; Gaytán F; Sánchez-Criado JE Biol Reprod; 1995 Nov; 53(5):1183-9. PubMed ID: 8527524 [TBL] [Abstract][Full Text] [Related]
58. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Chwalisz K Hum Reprod; 1994 Jun; 9 Suppl 1():131-61. PubMed ID: 7962460 [TBL] [Abstract][Full Text] [Related]
59. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. Kraus WL; Katzenellenbogen BS Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742 [TBL] [Abstract][Full Text] [Related]
60. Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice. Loutradis D; Bletsa R; Aravantinos L; Kallianidis K; Michalas S; Psychoyos A Hum Reprod; 1991 Oct; 6(9):1238-40. PubMed ID: 1752924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]